Mango Sciences Launches to Expand Global Access to Precision Medicine
Mango Sciences, Inc., a leading data science company focused on emerging markets, today announced how it plans to understand, manage, and solve the health challenges of underrepresented populations to enable precision medicine for billions of consumers. Formerly known as Enlightiks Inc. and owned by Practo Technologies, Inc., Mango Sciences continues to develop Querent™ – an advanced predictive artificial intelligence analytics platform that makes deep clinical data meaningful and accessible.
Emerging market consumers are routinely overlooked in health research and delivery. An overwhelming 86% of all clinical trial participants are of Caucasian origin though they make up only 16% of the world’s population. Consequently, the medical needs for a majority of the world’s population remain unmet whilst clinical insights from these populations, which could benefit everyone, are overlooked.
Mango Sciences is tackling this fundamental issue by connecting clinical research to patients of underrepresented communities. Partnering with hospitals and clinics in India and other emerging markets, the company’s platform unlocks key health insights from complex clinical data. By expanding access to global emerging market data, Mango Sciences can improve discovery in precision medicine and patient care for all populations.
